In DNCB-induced AD mouse model, puerarin treatment was associated with reduced expression of pruritogenic cytokines including IL-31 and TSLP, indicating its potential anti-inflammatory activity (Lee et al., 2018). Here, TSLP is linked to Alzheimer disease.